The intraperitoneal injection of DdBIC significantly suppressed tumor growth (Fig. 7j, top), with related events, including GSDMC and OPA1 cleavage, eIF2α phosphorylation, and a decrease in heme levels, detected in the same tumor samples (Fig. 7j, bottom). The gene discussed is EIF2A; the disease is neoplasm.